#pharmaceutical-sourcing
(5 articles)USMCA Strengthens North American Pharma Supply Chains
The USMCA trade agreement presents a strategic opportunity for pharmaceutical companies to strengthen regional supply chain resilience across North America. By leveraging preferential trade terms and
Trump's 200% Generic Drug Tariffs Threaten Pharma Supply Chains
The Trump administration's proposal to impose 200% tariffs on generic pharmaceuticals represents a structural shift in pharmaceutical trade policy with far-reaching supply chain consequences. The anno
Conflict Exposes Pharma Supply Chain Vulnerabilities
Recent geopolitical conflicts have exposed significant vulnerabilities within global pharmaceutical supply chains, highlighting the industry's heavy reliance on concentrated manufacturing hubs and fra
Trump's Drug Tariffs Force Pharma Supply Chain Rethink
The Trump administration's proposed tariffs on pharmaceuticals represent a structural shift in how the industry sources active pharmaceutical ingredients and finished drugs, potentially forcing manufa
Tariffs and Geopolitics Reshape Pharma Supply Chains
The pharmaceutical industry faces a critical inflection point as trade policy uncertainty and geopolitical tension force fundamental restructuring of global sourcing and distribution networks. Tariff
